PodParley PodParley
PodParley
Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19 episode artwork

EPISODE · Apr 14, 2021 · 7 MIN

Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19

from CONNECT older episodes · host CHQR / Curiouscast

Donald McCaffrey, President and CEO of Resverlogix.

Episode metadata supplied by the publisher feed · Published Apr 14, 2021

Embed this episode

NOW PLAYING

Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19

0:00 7:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CONNECT older episodes?

This episode is 7 minutes long.

When was this CONNECT older episodes episode published?

This episode was published on April 14, 2021.

Can I download this CONNECT older episodes episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!